Share

Electromagnetic fields promote osteogenesis of rat mesenchymal stem cells through the PKA and ERK1/2 pathways.

Yang Yong, Zhao Dong Ming, Li Feng, Zhao Wen Chun, Wu Hua

PAPERpubmedJournal of tissue engineering and regenerative medicine2016In vitro studyEffect: benefitEvidence: Low

Abstract

It has been reported that electromagnetic fields (EMFs) can promote the healing of non-union, osteogenesis and differentiation of the osteoblasts. However, its mechanism has not been unravelled. In this study, we detected some response induced by EMF and evaluated the importance of these signals for EMF-induced osteogenesis in bone marrow mesenchymal stem cells (MSCs). We characterized the expression of EMF-induced osteogenesis markers in MSCs, using RT-PCR and real-time PCR. Western blot was used to detect the signalling pathways. We found that EMF could promote osteogenesis in MSCs, along with the expression of several osteogenic markers. EMF-induced cyclic adenosine monophosphate (cAMP) level increase causes protein kinase A (PKA) and extracellular signal-regulated kinase (ERK)1/2 phosphorylation. Pretreating the MSCs with the mitogen-activated protein kinase (MAPK)/ERK kinase 1/2 (MEK1/2) inhibitor PD98059, or the PKA inhibitor H-89, significantly inhibited the induction of osteogenic markers, showing that EMF induction of osteogenesis was dependent on the ERK and PKA signalling pathways. Therefore, our study showed that EMF promoted MSC osteogenesis and that the EMF-induced osteogenic markers were mediated by both the PKA and MAPK signalling pathways. Copyright

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
benefit
Population
Rat bone marrow mesenchymal stem cells (MSCs)
Sample size
—
Exposure
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

EMF exposure promoted osteogenesis in rat bone marrow MSCs and increased expression of several osteogenic markers. EMF increased cAMP levels and was associated with PKA and ERK1/2 phosphorylation; inhibition of MEK1/2 (PD98059) or PKA (H-89) significantly inhibited induction of osteogenic markers, suggesting dependence on ERK and PKA pathways.

Outcomes measured

  • Osteogenesis in MSCs
  • Expression of osteogenic markers (RT-PCR/real-time PCR)
  • cAMP level changes
  • PKA phosphorylation/activation
  • ERK1/2 phosphorylation/activation
  • Effect of MEK1/2 inhibitor PD98059 on osteogenic marker induction
  • Effect of PKA inhibitor H-89 on osteogenic marker induction

Limitations

  • Exposure parameters (e.g.
  • frequency
  • intensity
  • duration) are not reported in the abstract.
  • In vitro study in rat cells
  • generalizability to in vivo or human outcomes is not addressed in the abstract.
  • Sample size and quantitative effect sizes are not provided in the abstract.
View raw extracted JSON
{
  "study_type": "in_vitro",
  "exposure": {
    "band": null,
    "source": null,
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Rat bone marrow mesenchymal stem cells (MSCs)",
  "sample_size": null,
  "outcomes": [
    "Osteogenesis in MSCs",
    "Expression of osteogenic markers (RT-PCR/real-time PCR)",
    "cAMP level changes",
    "PKA phosphorylation/activation",
    "ERK1/2 phosphorylation/activation",
    "Effect of MEK1/2 inhibitor PD98059 on osteogenic marker induction",
    "Effect of PKA inhibitor H-89 on osteogenic marker induction"
  ],
  "main_findings": "EMF exposure promoted osteogenesis in rat bone marrow MSCs and increased expression of several osteogenic markers. EMF increased cAMP levels and was associated with PKA and ERK1/2 phosphorylation; inhibition of MEK1/2 (PD98059) or PKA (H-89) significantly inhibited induction of osteogenic markers, suggesting dependence on ERK and PKA pathways.",
  "effect_direction": "benefit",
  "limitations": [
    "Exposure parameters (e.g., frequency, intensity, duration) are not reported in the abstract.",
    "In vitro study in rat cells; generalizability to in vivo or human outcomes is not addressed in the abstract.",
    "Sample size and quantitative effect sizes are not provided in the abstract."
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "electromagnetic fields",
    "EMF",
    "osteogenesis",
    "mesenchymal stem cells",
    "rat",
    "cAMP",
    "PKA",
    "ERK1/2",
    "MAPK",
    "MEK inhibitor",
    "PD98059",
    "H-89",
    "osteogenic markers"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 4696

Electromagnetic fields promote osteogenesis of rat mesenchymal stem cells through the PKA and ERK1/2 pathways. · Non-native EMF